IDH2 and central nervous system cancer: This epigenetic silencing contributes to uncontrolled cell proliferation and tumor growth, which is the hallmark of IDH‐mutant gliomas, alternatively called as the glioma‐associated CpG island methylator phenotype (G‐CIMP) [4, 35].